🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Drug Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are urged to contact these profiles directly for source information, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a robust trade exists on Telegram, where communities with thousands of participants share comparison photos, administration instructions and claims of rapid UK delivery. Vendors market the drug there before directing buyers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Professionals Express Concerns

Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could result in users injecting products of uncertain source.

Several experts stated the popularity for the experimental drug could be connected to the rising price of approved slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach medicines, advertising, and customer regulations, risking fines, legal action or prison.

Service Reaction and Content Removal

Based on TikTok, the service has taken down problematic material and prohibited associated keywords and query recommendations. The organization said it was dedicated to maintaining the service safe and investing in enhancing enforcement strategies.

Online Trading Activities

Research also found communities with up to 9,000 members selling retatrutide using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of users, populated with photos of weight loss, glowing reviews and detailed instructions for preparing or injecting at home.

After minutes of joining one group, a vendor shared WhatsApp details, where most transactions take place. The vendor sent an guidebook and promised delivery within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about weight, health issues or past usage.

Product Information and Costs

Inside these groups, posts show dark colored packages with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with sterile water, or pre-filled pens typically sold at 160 pounds for 20mg. When questioned how much time a pen should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A representative for the messaging service said it actively monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering substances they cannot confirm. Although the science behind this drug is sound, these digital versions may not contain what they claim,” said Jason Murphy, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in demand to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.

Her staff has previously seen patients injured by personal administration from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly investigational product not yet approved … may expose patients to potentially serious medical dangers”.